Major depressive disorder at adolescent age is associated with impaired cardiovascular autonomic regulation and vasculature functioning

Int J Psychophysiol. 2022 Nov:181:14-22. doi: 10.1016/j.ijpsycho.2022.08.004. Epub 2022 Aug 25.

Abstract

Cardiovascular adverse complications represent a risk factor for increased cardiovascular morbidity and mortality in patients with major depressive disorder (MDD). However, there is little knowledge of adolescent MDD. We aimed to study complex cardiovascular autonomic regulation and early atherosclerotic damage with a focus on an analysis of heart rate variability (HRV), blood pressure variability (BPV), systolic time intervals, and measures of early atherosclerotic changes in adolescent MDD. Ninety depressive adolescents (34 boys, age 15.8 ± 1.3 yrs.) and 90 age-/gender-matched controls were examined. Evaluated parameters: HRV - time and spectral parameters, BPV - mean, systolic, and diastolic blood pressure, spectral systolic parameters; haemodynamic indices - stroke volume, cardiac output, total peripheral resistance, systolic time intervals - left ventricular ejection time, pre-ejection period; atherosclerotic indices - ankle-brachial index (ABI), pulse wave velocity, brachial-ankle pulse wave velocity, cardio-ankle vascular index; growth factors - epidermal growth factor (EGF), vascular endothelial growth factor associated with monocyte chemoattractant protein-1. Our results showed that the MDD group had significantly reduced HRV and higher BPV measures, shortened systolic time intervals, lower ABI, and higher EGF compared to controls. Concluding, our study revealed that adolescent MDD is associated with cardiovascular dysregulation and early vasculature dysfunction as preclinical markers of higher risk for cardiovascular morbidity, thus adolescence seems to represent an important age period for early diagnosis and prevention of later MDD-linked cardiovascular diseases manifesting in adulthood.

Keywords: Adolescent major depression; Blood pressure variability; Cardiovascular autonomic regulation; Cardiovascular risk; Heart rate variability; Preclinical atherosclerosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Ankle Brachial Index
  • Blood Pressure / physiology
  • Cardiovascular Diseases*
  • Chemokine CCL2 / therapeutic use
  • Depressive Disorder, Major*
  • Epidermal Growth Factor / therapeutic use
  • Heart Rate / physiology
  • Humans
  • Male
  • Pulse Wave Analysis
  • Vascular Endothelial Growth Factor A / therapeutic use

Substances

  • Chemokine CCL2
  • Vascular Endothelial Growth Factor A
  • Epidermal Growth Factor